Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1581 (Rev 09/2005) |
OMB No. 0651-0054 (Exp 12/31/2020) |
Request for Extension of Time to File a Statement of Use
(15 U.S.C. Section 1051(d))
The table below presents the data as entered.
Input Field
|
Entered
|
SERIAL NUMBER |
88297656 |
LAW OFFICE ASSIGNED |
LAW OFFICE 116 |
MARK SECTION |
MARK |
THERGY (see, http://uspto.report/TM/88297656/mark.png) |
STANDARD CHARACTERS |
YES |
USPTO-GENERATED IMAGE |
YES |
LITERAL ELEMENT |
THERGY |
OWNER SECTION (current) |
NAME |
Anjon Biologics, Inc. |
MAILING ADDRESS |
220 Adams Drive #280 / 221 |
CITY |
Weatherford |
STATE |
Texas |
ZIP/POSTAL CODE |
76086 |
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY |
United States |
OWNER SECTION (proposed) |
NAME |
Anjon Biologics, Inc. |
MAILING ADDRESS |
220 Adams Drive #280 / 221 |
CITY |
Weatherford |
STATE |
Texas |
ZIP/POSTAL CODE |
76086 |
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY |
United States |
EMAIL |
XXXX |
CORRESPONDENCE INFORMATION (current) |
NAME |
LAUREN BETH EMERSON |
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE |
tmdocket@leasonellis.com |
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) |
NOT PROVIDED |
CORRESPONDENCE INFORMATION (proposed) |
NAME |
Lauren Beth Emerson |
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE |
tmdocket@leasonellis.com |
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) |
NOT PROVIDED |
DOCKET/REFERENCE NUMBER |
11414/312432 |
GOODS AND/OR SERVICES SECTION |
INTERNATIONAL CLASS |
005 |
CURRENT IDENTIFICATION |
Oral spray for treatment of mucositis; oral spray for treatment of inflammation and lesions caused by radiation and chemotherapy;
pharmaceutical preparations for the treatment of cancer |
GOODS OR SERVICES DELETED FROM THE APPLICATION |
Oral spray for treatment of mucositis; oral spray for treatment of inflammation and lesions caused by radiation and chemotherapy |
GOODS OR SERVICES FOR WHICH APPLICANT HAS A CONTINUED BONA FIDE INTENTION, AND IS ENTITLED, TO USE |
pharmaceutical preparations for the treatment of cancer |
EXTENSION SECTION |
EXTENSION NUMBER |
2 |
ONGOING EFFORT |
product or service research or development |
ALLOWANCE MAIL DATE |
07/09/2019 |
STATEMENT OF USE |
NO |
PAYMENT SECTION |
NUMBER OF CLASSES |
1 |
SUBTOTAL AMOUNT [EXTENSION FEE] |
125 |
TOTAL AMOUNT |
125 |
SIGNATURE SECTION |
SIGNATURE |
/Robert Breeze/ |
SIGNATORY'S NAME |
Breeze, Robert |
SIGNATORY'S POSITION |
C.E.O. |
DATE SIGNED |
07/07/2020 |
SIGNATORY'S PHONE NUMBER |
855-434-0300 |
FILING INFORMATION |
SUBMIT DATE |
Tue Jul 07 16:00:43 ET 2020 |
TEAS STAMP |
USPTO/ESU-XX.XX.XX.XX-202
00707160043076757-8829765
6-71076fd43dc501db99062a3
1139f6c0719d492624789fd44
06a5b7edfa1bc678743-CC-00
408529-202007070934399193
27 |
Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1581 (Rev 09/2005) |
OMB No. 0651-0054 (Exp 12/31/2020) |
SOU Extension Request
(15 U.S.C. Section 1051(d))
To the Commissioner for Trademarks:
MARK: THERGY (see, http://uspto.report/TM/88297656/mark.png)
SERIAL NUMBER: 88297656
OWNER AND/OR ENTITY INFORMATION
The owner proposes to amend the following:
Current: Anjon Biologics, Inc., having an address of
220 Adams Drive #280 / 221
Weatherford, Texas 76086
United States
Proposed: Anjon Biologics, Inc., having an address of
220 Adams Drive #280 / 221
Weatherford, Texas 76086
United States
Phone:
Fax:
Email: XXXX
The owner requests a six-month extension of time to file the Statement of Use under 37 C.F.R. Section 2.89 in this application. The Notice of Allowance mailing date was 07/09/2019.
For International Class 005:
Current identification: Oral spray for treatment of mucositis; oral spray for treatment of inflammation and lesions caused by radiation and chemotherapy; pharmaceutical preparations for the treatment
of cancer
This filing does
NOT cover the following goods/services listed in either the application or Notice of Allowance or as subsequently modified for this specific class; these goods/services are
permanently deleted from this application: Oral spray for treatment of mucositis; oral spray for treatment of inflammation and lesions caused by radiation and chemotherapy
For a trademark/service mark: The applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all of the goods/services listed in the Notice
of Allowance or as subsequently modified for this specific class; for a collective/certification mark: the applicant has a continued bona fide intention, and is entitled, to exercise legitimate
control over the use of the mark in commerce on or in connection with the goods/services/collective membership organization listed in the Notice of Allowance, or as subsequently modified for this
specific class: pharmaceutical preparations for the treatment of cancer
This is the second extension request. The applicant has made the following ongoing efforts to use the mark in commerce on or in connection with each of those goods/services covered by the extension
request: product or service research or development
Correspondence Information (current):
LAUREN BETH EMERSON
PRIMARY EMAIL FOR CORRESPONDENCE: tmdocket@leasonellis.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): NOT PROVIDED
Correspondence Information (proposed):
Lauren Beth Emerson
PRIMARY EMAIL FOR CORRESPONDENCE: tmdocket@leasonellis.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): NOT PROVIDED
Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the owner/holder and the owner's/holder's attorney, if appointed, and that all
official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).
A fee payment in the amount of $125 will be submitted with the form, representing payment for 1 class.
Declaration
STATEMENTS: The signatory believes that: the applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all the goods/services under Section
1(b) in the notice of allowance or as subsequently modified, or, if applicable, the applicant has a continued bona fide intention, and is entitled, to exercise legitimate control over the use of the
mark in commerce on or in connection with all the goods/services/collective membership organization under Section 1(b) in the notice of allowance or as subsequently modified; and that to the best of
the signatory's knowledge and belief, no other persons, except, if applicable, members and concurrent users, have the right to use the mark in commerce, either in the identical form or in such near
resemblance as to be likely, when used on or in connection with the goods/services/collective membership organization of such other persons, to cause confusion or mistake, or to deceive.
DECLARATION: The signatory being warned that willful false statements and the like are punishable by fine or imprisonment, or both, under 18 U.S.C. §1001, and that such willful false statements and
the like may jeopardize the validity of the application or submission or any resulting registration, declares that all statements made of his/her own knowledge are true and that all statements made
on information and belief are believed to be true.
Signature: /Robert Breeze/ Date Signed: 07/07/2020
Signatory's Name: Breeze, Robert
Signatory's Position: C.E.O.
Signatory's Phone: 855-434-0300
RAM Sale Number: 88297656
RAM Accounting Date: 07/07/2020
Serial Number: 88297656
Internet Transmission Date: Tue Jul 07 16:00:43 ET 2020
TEAS Stamp: USPTO/ESU-XX.XX.XX.XX-202007071600430767
57-88297656-71076fd43dc501db99062a31139f
6c0719d492624789fd4406a5b7edfa1bc678743-
CC-00408529-20200707093439919327